Zentalis Pharma Stock (NASDAQ: ZNTL) stock price, news, charts, stock research, profile.
You can purchase shares of Zentalis Pharma (NASDAQ:ZNTL) through any online brokerage.
Other companies in Zentalis Pharma’s space includes: Macrogenics (NASDAQ:MGNX), Molecular Partners (NASDAQ:MOLN), Renovaro (NASDAQ:RENB), Precigen (NASDAQ:PGEN) and Inozyme Pharma (NASDAQ:INZY).
Zentalis Pharma has a consensus price target of $18.10.
The stock price for Zentalis Pharma (NASDAQ: ZNTL) is $3 last updated December 20, 2024 at 6:01 PM EST.
There are no upcoming dividends for Zentalis Pharma.
Zentalis Pharma’s FY earnings are confirmed for Tuesday, February 25, 2025.
There is no upcoming split for Zentalis Pharma.
Zentalis Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.